18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

Ambulatory surgery accounts for over $70%$ of all elective surgical procedures performed in North America. Successful outpatient anesthesia requires stringent patient and procedure selection, proactive risk management, and the implementation of Enhanced Recovery After Surgery (ERAS) protocols designed to minimize postoperative pain, nausea, and convalescence time.

---

1. Ambulatory Patient & Procedure Selection Guidelines

Appropriateness for the ambulatory surgery center (ASC) setting is dictated by the interaction between the patient's medical status, the invasiveness of the surgical procedure, and social support systems.

+---------------------------------------------------------------------------------------------------------+
|                                 AMBULATORY SURGERY SELECTION FRAMEWORK                                  |
+-----------------------+--------------------------------------+------------------------------------------+
| Domain                | Appropriate for Ambulatory Center    | Excluded / Requires Hospital Admission   |
+-----------------------+--------------------------------------+------------------------------------------+
| **ASA Status**        | • ASA Class I & II                   | • Unstable ASA Class III or Class IV     |
|                       | • **Optimized, stable ASA Class III**| • Acute organ failure or decompensation  |
+-----------------------+--------------------------------------+------------------------------------------+
| **Cardiopulmonary**   | • Controlled hypertension, mild CAD  | • Unstable angina, recent MI (<60 days)  |
|                       | • Well-controlled asthma / COPD      | • Symptomatic severe aortic stenosis     |
|                       | • Compliant OSA with CPAP access     | • Severe pulmonary hypertension, decomp HF|
+-----------------------+--------------------------------------+------------------------------------------+
| **Pediatric Age**     | • Full-term infants > 44 weeks PCA   | • **Ex-premature infants < 60 weeks PCA**|
|                       | • Children without active apnea      |   (mandatory overnight apnea monitoring) |
+-----------------------+--------------------------------------+------------------------------------------+
| **Substance & Social**| • Responsible adult escort available | • Acute intoxication / active withdrawal |
|                       | • Patient capable of home self-care  | • No responsible adult caregiver at home |
+-----------------------+--------------------------------------+------------------------------------------+
| **Surgical Factors**  | • Minimal anticipated blood loss     | • Major cavity exploration, open thorax  |
|                       | • Duration typically < 3 - 4 hours   | • High risk for major fluid shifts/hemorr|
|                       | • Postop pain manageable with oral Rx| • Mandatory prolonged immobilizing care  |
+-----------------------+--------------------------------------+------------------------------------------+

The Ex-Premature Infant: Post-Conceptual Age (PCA) Rule

• Post-Conceptual Age Calculation: $\text{PCA (weeks)} = \text{Gestational Age at Birth (weeks)} + \text{Chronological Age (weeks)}$
• Apnea Risk: Former premature infants ($<37 \text{ weeks}$ gestation) have immature central respiratory centers and are at high risk for life-threatening postoperative apnea, bradycardia, and hypoxemia for up to $12 - 24 \text{ hours}$ following general anesthesia.
• The 60-Week Cutoff Standard: Any ex-premature infant whose $\text{PCA} < 60 \text{ weeks}$ must NOT undergo elective outpatient surgery in a freestanding ASC. They require surgery in a hospital setting followed by continuous inpatient cardiorespiratory (apnea) monitoring for at least $12 - 24 \text{ hours}$ postoperatively.

Malignant Hyperthermia (MH) Susceptibility in the ASC

• Patients with known or suspected MH susceptibility CAN safely undergo elective procedures in an ambulatory surgery center provided specific safety criteria are satisfied:
  1. Total Trigger-Free Anesthesia: Absolute avoidance of all volatile inhalational agents (sevoflurane, desflurane, isoflurane) and succinylcholine. Use Propofol TIVA, local/regional anesthesia, or nitrous oxide.
  2. Anesthesia Machine Preparation: Vaporizers removed or physically locked; machine flushed with high-flow $100% \text{ O}_2$ ($10 \text{ L/min}$ for $20 - 90 \text{ minutes}$ according to manufacturer guidelines) or activated charcoal filters (Vapor-Clean) placed on inspiratory and expiratory limbs.
  3. Stocked Reversal Agent: The facility must have a complete MH emergency cart containing Dantrolene (36 vials of $20 \text{ mg}$) or Ryanodex (3 vials of $250 \text{ mg}$) with sterile water for reconstitution.
  4. Postoperative Observation: Observe in Phase I/II PACU for at least $60 - 90 \text{ minutes}$; if uneventful, the patient may be safely discharged home.

---

2. Enhanced Recovery After Surgery (ERAS) Care Pathways

ERAS represents a multidisciplinary, evidence-based paradigm that attenuates the surgical stress response, maintains physiological homeostasis, reduces organ dysfunction, and accelerates post-surgical recovery.

+---------------------------------------------------------------------------------------------------------+
|                                    ERAS PERIOPERATIVE CARE CONTINUUM                                    |
+-----------------------+--------------------------------------+------------------------------------------+
| Perioperative Phase   | Core Evidence-Based Interventions    | Physiologic Rationale & Outcome          |
+-----------------------+--------------------------------------+------------------------------------------+
| **Preoperative**      | • Fasting: Clear liquids up to 2h    | • Attenuates catabolism, dehydration,    |
|                       | • **Carbohydrate Loading (maltodex)**|   and postop insulin resistance          |
|                       | • Pre-emptive multimodal non-opioid  | • Acetaminophen + Celecoxib + Gabapentin |
|                       |   analgesia (oral)                   |   attenuates central/peripheral sensitiz |
+-----------------------+--------------------------------------+------------------------------------------+
| **Intraoperative**    | • **Opioid-Sparing Multimodal TIVA** | • Propofol TIVA + Lidocaine/Ketamine inf |
|                       | • Regional / Fascial Plane Blocks    | • TAP, ESP, Rectus sheath, Adductor canal|
|                       | • **Goal-Directed Fluid Rx (GDFT)**  | • Protects endothelial glycocalyx        |
|                       | • Prophylactic Antiemetic Dual/Triple| • Dexamethasone + Ondansetron + Scopolam |
|                       | • **Active Normothermia (>36.0°C)**  | • Warming blankets reduce SSI & bleeding |
+-----------------------+--------------------------------------+------------------------------------------+
| **Postoperative**     | • **Early Oral Nutrition** (liquids) | • Accelerates return of bowel motility   |
|                       | • **Early Ambulation** within hours  | • Prevents VTE, atelectasis, ileus       |
|                       | • Prompt urinary catheter removal    | • Reduces CAUTI, promotes mobilization   |
|                       | • Transition to oral non-opioid meds | • Minimizes opioid-induced bowel dysfunct|
+-----------------------+--------------------------------------+------------------------------------------+

                    [THE MULTIMODAL OPIOID-SPARING BUNDLE]

                            [SURGICAL TRAUMA]
                                    |
     +--------------------+---------+---------+--------------------+
     |                    |                   |                    |
     v                    v                   v                    v
[COX-2 Inhibitor]  [Acetaminophen]     [IV Lidocaine]       [Ketamine]
  (Celecoxib)        (Central COX)       (Sodium Channel      (NMDA Receptor
Peripheral Prosta-  Antipyretic /       & Anti-Inflammatory) Antagonist)
glandin Blockade    Analgesic           Suppresses Ectopic   Prevents Central
                                        Neural Firing        Wind-Up / Hyperalg
     |                    |                   |                    |
     +--------------------+---------+---------+--------------------+
                                    |
                                    v
                     **OPIOID CONSUMPTION ↓ 50-70%**
                     **PONV ↓, ILEUS ↓, SEDATION ↓**

Intraoperative Non-Opioid Adjuvants

1. Intravenous Lidocaine Infusion:
   • Loading Dose: $1.0 - 1.5 \text{ mg/kg}$ IV bolus at induction.
   • Continuous Infusion: $1.5 - 2.0 \text{ mg/kg/h}$ throughout surgery.
   • Benefits: Sodium channel blockade suppresses spontaneous pain transmission, attenuates visceral peritoneal pain, accelerates bowel motility recovery, and exerts systemic anti-inflammatory effects.
2. Subanesthetic Ketamine Infusion:
   • Loading Dose: $0.2 - 0.5 \text{ mg/kg}$ IV bolus.
   • Continuous Infusion: $0.1 - 0.25 \text{ mg/kg/h}$ ($2 - 4 \text{ mcg/kg/min}$).
   • Benefits: Non-competitive antagonism of $N$-methyl-$D$-aspartate (NMDA) receptors prevents spinal dorsal horn neuronal "wind-up," prevents acute opioid-induced hyperalgesia (OIH), and significantly reduces postoperative morphine consumption.
3. Dexmedetomidine (Precedex):
   • Selective $\alpha_2$-agonist ($0.2 - 0.5 \text{ mcg/kg/h}$) providing sedation, anxiolysis, and analgesia without respiratory depression.

Goal-Directed Fluid Therapy (GDFT) & Glycocalyx Integrity

• Static vs. Dynamic Measures: Static parameters (Central Venous Pressure [CVP], blood pressure, heart rate) correlate poorly with fluid responsiveness. GDFT relies on dynamic cardiopulmonary interactions during positive-pressure mechanical ventilation:
  • Stroke Volume Variation ($SVV$): Normal $\le 10 - 12%$. $SVV > 12 - 13%$ indicates fluid responsiveness.
  • Pulse Pressure Variation ($PPV$): $PPV > 13%$ indicates fluid responsiveness (requires tidal volume $\ge 8 \text{ mL/kg}$, sinus rhythm, and closed chest).
• Protecting the Endothelial Glycocalyx: Hypervolemia causes secretion of Atrial Natriuretic Peptide (ANP), which degrades the fragile endothelial glycocalyx barrier, promoting interstitial fluid extravasation, tissue edema, pulmonary compromise, and prolonged postoperative ileus. GDFT targets euvolemia with balanced crystalloids ($1 - 3 \text{ mL/kg/h}$ maintenance plus targeted boluses).

---

3. Fast-Tracking & Post-Anesthesia Recovery Scoring

Fast-tracking refers to the clinical pathway wherein patients emerging from general, regional, or MAC anesthesia bypass the Phase I PACU and are transferred directly from the operating room to the Step-Down Phase II unit.

+---------------------------------------------------------------------------------------------------------+
|                                 WHITE-SONG FAST-TRACK SCORING SYSTEM                                    |
+-------------------------+---------------------------------------------------------------------+---------+
| Assessment Category     | Clinical Evaluation Criteria                                        | Score   |
+-------------------------+---------------------------------------------------------------------+---------+
| **1. Physical Activity**| • Moves all 4 extremities voluntarily or on command                 | 2       |
|                         | • Moves 2 extremities voluntarily                                   | 1       |
|                         | • Unable to move extremities                                        | 0       |
+-------------------------+---------------------------------------------------------------------+---------+
| **2. Hemodynamics**     | • Blood pressure within ± 15% of preop baseline                     | 2       |
|                         | • Blood pressure within ± 15% to 30% of baseline                    | 1       |
|                         | • Blood pressure within ± >30% of baseline                          | 0       |
+-------------------------+---------------------------------------------------------------------+---------+
| **3. Respiratory**      | • Breathes easily, normal rate and depth, coughs freely             | 2       |
|                         | • Dyspneic, shallow breathing, requires oral/nasal airway           | 1       |
|                         | • Apneic / requires mechanical ventilation                          | 0       |
+-------------------------+---------------------------------------------------------------------+---------+
| **4. Consciousness**    | • Fully awake, alert, and oriented to person, place, time           | 2       |
|                         | • Arousable by verbal stimuli                                       | 1       |
|                         | • Unresponsive / responds only to painful stimuli                   | 0       |
+-------------------------+---------------------------------------------------------------------+---------+
| **5. Oxygen Saturation**| • SpO₂ > 92% on room air                                            | 2       |
|                         | • Requires supplemental O₂ to maintain SpO₂ > 90%                   | 1       |
|                         | • SpO₂ < 90% despite supplemental O₂                                | 0       |
+-------------------------+---------------------------------------------------------------------+---------+
| **6. Postoperative Pain**| • None or mild discomfort (Visual Analog Scale 0 - 2)              | 2       |
|                         | • Moderate pain controllable with non-opioids (VAS 3 - 5)           | 1       |
|                         | • Severe persistent pain requiring IV opioids (VAS > 5)             | 0       |
+-------------------------+---------------------------------------------------------------------+---------+
| **7. Emetic Symptoms**  | • No nausea or vomiting                                             | 2       |
|                         | • Transient mild nausea successfully treated with oral fluids/meds  | 1       |
|                         | • Persistent nausea or vomiting requiring parenteral antiemetics    | 0       |
+-------------------------+---------------------------------------------------------------------+---------+

$\mathbf{\text{Fast-Track Transfer Criteria: Total Score } \ge 12 / 14 \quad (\text{with NO individual score } < 1)}$

Ambulatory Discharge to Home: Post-Anesthesia Discharge Scoring System (PADSS)

Prior to home discharge from Phase II, the patient must achieve a $\text{PADSS} \ge 9 / 10$ across 5 categories: vital signs, ambulation, nausea/vomiting, pain, and surgical bleeding.

• Modern Standard: Routine mandatory voiding and mandatory oral liquid intake are no longer required for all patients prior to discharge unless specifically indicated (e.g., neuraxial anesthesia, pelvic/groin surgery, history of urinary retention).